Allergan Breast Implants in AustinThe most studied implant system in the world — placed by Dr. Jeffrey Hall, ABPS board-certified
Allergan® breast implants have the longest post-market safety dataset of any implant system available — backed by decades of FDA-mandated follow-up, the broadest profile selection in the industry, and a documented warranty program. Hall Plastic Surgery offers Allergan alongside Motiva, and Dr. Jeffrey Hall recommends the system that fits your anatomy, goals, and priorities. Appointments at Westlake and Cedar Park.
What are Allergan breast implants?
Allergan breast implants (now manufactured by AbbVie) are FDA Pre-Market Approved (PMA) silicone and saline breast implants with the longest continuous post-market safety surveillance record of any implant system available in the United States. The INSPIRA® silicone collection offers round implants across five projection profiles — from low to extra-full — providing the broadest anatomical fit range in the industry. Allergan’s saline implants are FDA-approved for patients 18 and older; silicone implants for patients 22 and older.
Allergan’s primary clinical distinction is not a single technology innovation — it is a comprehensive, decades-long body of evidence. FDA-mandated core and adjunct studies have followed thousands of Allergan augmentation patients for 10 years and beyond. That dataset answers questions about rupture rates, reoperation rates, capsular contracture incidence, and patient-reported satisfaction that no newer implant system can yet match because the follow-up time simply does not exist.
For patients who weight the longest available safety record above all other factors — or for whom the FDA’s full U.S. PMA approval is a non-negotiable criterion — Allergan is the straightforward choice. Dr. Hall presents this reasoning explicitly at consultation and does not redirect patients who have reached this conclusion based on their own research.
Hall Plastic Surgery offers Allergan alongside Motiva. Dr. Hall’s recommendation is based on your specific anatomy, tissue coverage, and what you actually care about — not on which system carries higher margins or is more fashionable at a given moment.
Hall Plastic Surgery — Westlake, Austin TX · Allergan® breast augmentation by Dr. Jeffrey Hall
The Allergan INSPIRA® collection — what’s actually available.
Allergan’s INSPIRA® round silicone implants are the most widely used implant collection in the world. The profile range — from Soft Touch to Extra Full — is what gives Allergan its anatomical fit advantage: a surgeon can select the exact projection-to-base-width ratio that fits a specific chest wall precisely, rather than approximating with a limited range.
Cohesive Silicone Gel
Allergan uses a highly cohesive silicone gel that maintains its form if the shell is compromised — the gel does not flow freely. Cohesion level is calibrated per collection: softer for natural-feel variants, firmer for high-profile options where shape retention matters more. The gel chemistry is backed by decades of FDA post-market study data on gel bleed, rupture behavior, and tissue response.
Smooth Shell
Current Allergan round silicone implants use a smooth shell — the same surface class as Motiva’s SmoothSilk®, and importantly, the surface class associated with the lowest BIA-ALCL risk. Allergan’s BIOCELL® textured implants were voluntarily withdrawn from the U.S. market in 2019 following FDA concerns about BIA-ALCL incidence. Hall Plastic Surgery places only smooth-shelled Allergan implants.
FDA PMA Approval
Allergan holds full FDA Pre-Market Approval for both silicone gel (patients 22+) and saline (patients 18+) implants — the highest regulatory standard for implantable medical devices in the United States. PMA requires clinical evidence of safety and effectiveness, plus ongoing post-approval study commitments that have generated the most comprehensive implant safety dataset in existence.
Five Projection Profiles
INSPIRA® round implants are available in Low, Moderate, Full, Extra-Full, and High projection profiles across a wide base width range. This breadth means Dr. Hall can match the exact projection-to-base-width ratio to a patient’s chest wall dimensions rather than choosing the closest available approximation. No other implant system offers as many precisely calibrated anatomical options.
Saline Implants (18+)
Allergan saline implants are FDA-approved for patients 18 and older — four years younger than the silicone approval threshold. They are filled with sterile saline after insertion, allowing a slightly smaller incision. If the shell ruptures, the deflation is immediate and visible — a feature some patients specifically prefer over the silent rupture of silicone. Saline implants feel firmer than silicone and are more prone to visible rippling in thin-tissue patients.
Warranty & Replacement Program
Allergan’s ConfidencePlus® warranty program provides replacement implants at no charge for confirmed rupture (lifetime) and significantly reduced surgical fees for capsular contracture Grade III–IV within 10 years. The program is well-documented, has a long operational history, and patients know exactly what is covered before surgery — not after a complication occurs.
Choosing the right Allergan profile — how Dr. Hall approaches it.
Profile selection is a clinical decision based on chest wall width, existing tissue volume, and your desired outcome — not cup size targets. The table below explains what each profile provides and which patient anatomy it fits best. Dr. Hall uses these as a framework at consultation, then refines the selection using physical measurements and sizers.
| Profile | Projection | Base Width | Best suited for |
|---|---|---|---|
| Soft Touch (Low) | Lowest forward projection per volume | Wider base for given volume | Wider chest walls; patients wanting subtle enhancement with maximum base fill |
| Moderate | Balanced projection | Moderate for given volume | Average chest width; most common starting point for primary augmentation patients |
| Full Most common | Noticeably forward projection | Moderate-narrow | Average-to-narrower chest; strong upper pole fill; the most frequently placed profile at Hall Plastic Surgery |
| Extra Full | High projection, concentrated forward | Narrower base per volume | Narrower chest walls; patients wanting maximum volume from a given base width; post-mastectomy or significant volume deficit cases |
| High | Maximum projection per volume | Narrowest base per volume | Very narrow chest walls; patients specifically requesting the highest projection-to-base ratio available |
Profile selection at Hall Plastic Surgery is made using base width measurement, existing tissue volume, and physical sizers at consultation — not by target cup size or by patient-selected profile preference alone.
Allergan vs. Motiva — an honest comparison.
Dr. Hall offers both systems because both are clinically appropriate in different patient profiles. Here is the comparison as he presents it at consultation — without manufacturer bias in either direction.
Allergan®
Proven long-term record- Regulatory status: Full FDA PMA approval for silicone (22+) and saline (18+) implants in the United States — the highest regulatory standard available.
- Track record: The most extensively studied implant system in the world. Decades of FDA-mandated post-market data on rupture rates, reoperation, and patient satisfaction.
- Profile range: Five INSPIRA® projection profiles across a comprehensive base width matrix — broadest fit precision of any implant system.
- Saline option: Available for patients 18+ who prefer saline — immediate visible deflation if rupture occurs, smaller incision at insertion.
- Warranty: ConfidencePlus® — lifetime implant replacement for confirmed rupture, reduced surgical fees for Grade III–IV capsular contracture within 10 years.
- Feel: Excellent cohesive silicone — though gel formulation does not match Motiva’s progressive density profile in thin-tissue patients.
- Surface: Smooth shell — same low BIA-ALCL risk profile as Motiva smooth; macro-textured BIOCELL® no longer placed at Hall Plastic Surgery.
Motiva®
Engineering-forward- Regulatory status: Approved in 80+ countries; U.S. FDA PMA process ongoing. Not yet a full FDA PMA holder in the United States.
- Track record: Excellent published outcomes data with growing post-market follow-up — though long-term dataset does not yet match Allergan’s decades of FDA-mandated surveillance.
- Feel: Progressive gel fill produces the most natural tissue-like feel of any current implant — most pronounced advantage in thin-tissue patients.
- Movement: Ergonomix® gravity-responsive round implant mimics natural tissue dynamics — a meaningful performance advantage over static implant designs.
- Rippling: TrueMonobloc® core significantly reduces rippling risk — strongest advantage for patients with thin overlying tissue coverage.
- Traceability: Q Inside® NFC chip allows non-invasive implant identification at any time post-operatively — no equivalent in Allergan system.
- Saline option: Not available — Motiva implants are silicone gel only.
Dr. Hall’s clinical position: For patients who require full U.S. FDA PMA approval as a non-negotiable criterion, or who prioritize the longest available post-market safety dataset above all else, Allergan is the appropriate recommendation — full stop. For patients with adequate tissue coverage where the implant-specific feel difference between systems is less perceptible, Allergan’s broader profile range and established track record make it an excellent default choice for primary augmentation. Motiva’s advantages are most pronounced in thin-tissue patients where progressive gel and rippling reduction matter most.
Who is the right candidate for Allergan implants?
Allergan implants are appropriate for the full range of breast augmentation candidates — they are not a specialty product for a narrow patient profile. The question is not whether Allergan is appropriate, but whether Motiva’s specific engineering advantages are compelling enough to matter for your particular anatomy and priorities.
Allergan is specifically the stronger recommendation for:
- Patients for whom full U.S. FDA PMA approval is a primary or non-negotiable criterion in implant selection
- Patients who prioritize the longest available post-market safety dataset — decades of FDA-mandated follow-up data that no newer system can currently match
- Patients 18–21 years old who want breast augmentation and meet candidacy criteria — Allergan saline is FDA-approved at 18, four years earlier than any silicone implant
- Patients who specifically prefer saline implants — for visible rupture detection, slightly smaller incision, or personal preference
- Patients with adequate or substantial native breast tissue coverage where the feel difference between Allergan and Motiva will not be perceptible
- Patients with wider chest walls who benefit from Allergan’s broader low-projection profile options that Motiva does not fully replicate
- Patients who want the most established warranty and replacement program in the industry — ConfidencePlus® with a documented operational history
Dr. Hall evaluates tissue coverage, chest wall dimensions, age, and stated priorities at consultation. For patients with thin tissue where rippling is a concern, he discusses Motiva’s TrueMonobloc® advantage directly. For everyone else, Allergan is an excellent and in many cases the preferred choice.
Allergan advantage is strongest when:
- Full FDA PMA approval required
- Longest safety record is top priority
- Saline implants preferred
- Age 18–21 (saline only)
- Adequate tissue coverage present
- Wider chest wall anatomy
- Established warranty program valued
- Primary augmentation, standard anatomy
How implant selection works at Hall Plastic Surgery.
Implant selection is a clinical recommendation — not a catalog choice or a marketing decision. Here is the process Dr. Hall follows at every augmentation consultation, regardless of which system a patient is leaning toward when they walk in.
Tissue coverage assessment
Dr. Hall evaluates your native breast tissue volume, skin thickness, and degree of coverage at physical examination. Tissue coverage is the most important variable in implant selection — it determines how perceptible implant-specific differences (rippling, edge definition, feel) will be in your specific body. This assessment precedes any implant recommendation.
Chest wall measurement
Dr. Hall measures your breast base width — the anatomical footprint of the breast on your chest wall. Base width is the primary constraint in Allergan profile selection: the implant’s base must match your chest wall dimensions within a specific tolerance or the result will look and feel wrong regardless of how aesthetically pleasing the volume is in isolation.
Goals and priorities conversation
Dr. Hall asks what matters most: natural feel, the longest FDA safety record, saline as an option, or specific volume targets. For patients who walk in having already decided on Allergan based on FDA approval or post-market data — a position Dr. Hall considers entirely reasonable — the conversation moves directly to profile selection rather than relitigating the system choice.
Profile selection with sizers
Within the Allergan INSPIRA® range, Dr. Hall selects a profile based on your base width measurement, desired projection, and volume goals. Physical sizers are used at consultation so you can experience the volume before committing — a step that is particularly valuable with Allergan’s wide profile range because small profile differences produce meaningfully different aesthetic outcomes.
Silicone vs. saline decision
For patients considering saline — whether for the age qualification, visible rupture preference, or personal choice — Dr. Hall explains the trade-offs honestly: saline feels firmer, ripples more visibly in thin-tissue patients, and is filled to volume in the operating room rather than pre-filled. For patients 22+ with adequate tissue coverage who do not have a specific reason to prefer saline, silicone is typically the recommendation.
Dr. Jeffrey Hall — Allergan provider, ABPS board-certified, Austin TX.
Dr. Hall has been placing Allergan breast implants in Austin for over 25 years — predating many of the post-market study requirements that now make Allergan’s safety dataset the gold standard in the industry. He is certified by the American Board of Plastic Surgery (ABPS), continuously since 1997, and is an active member of the American Society of Plastic Surgeons (ASPS) and the Texas Medical Association.
The depth of Dr. Hall’s experience with Allergan implants matters specifically because the full profile range — five INSPIRA® projections across a wide base width matrix — is only useful when the surgeon has the anatomical judgment to select precisely within it. A surgeon who primarily uses a narrow subset of profiles is not fully leveraging Allergan’s fit precision advantage. Dr. Hall’s 25+ years of case volume means he has placed implants across the full range of anatomies the INSPIRA® collection is designed to address.
His approach to the Allergan-versus-Motiva question is consistent: he presents both systems accurately, makes a recommendation based on anatomy and stated priorities, and does not steer patients away from a well-reasoned decision they arrived at through their own research. Patients who come in committed to Allergan based on FDA approval status and post-market record are making a clinically sound choice. He respects that and plans accordingly.
What patients say about Hall Plastic Surgery.
4.9★ across 342 verified Google reviews. Read what Austin-area patients say about their breast augmentation experience with Dr. Hall.
Allergan breast implants — questions patients actually ask.
Allergan breast implants (manufactured by AbbVie) are FDA Pre-Market Approved silicone and saline implants with the most extensive post-market safety surveillance record of any implant system available. The INSPIRA® silicone collection offers five projection profiles — from Low to High — across a comprehensive base width range, providing the broadest anatomical fit precision in the industry. Allergan saline implants are FDA-approved for patients 18+; silicone implants for patients 22+.
Yes. Allergan holds full FDA Pre-Market Approval (PMA) for both silicone gel (patients 22+) and saline (patients 18+) breast implants — the highest regulatory standard for implantable medical devices in the United States. PMA requires clinical evidence of safety and effectiveness, plus post-approval study commitments. Allergan has maintained FDA PMA status continuously and complied with decades of post-market surveillance requirements.
In July 2019, Allergan voluntarily recalled and ceased distribution of its BIOCELL® textured breast implants and tissue expanders following a request from the FDA, based on data showing a significantly elevated risk of Breast Implant-Associated Anaplastic Large Cell Lymphoma (BIA-ALCL) compared to smooth-surfaced implants. BIA-ALCL is a rare type of non-Hodgkin lymphoma associated with the capsule around the implant, not the breast tissue itself. Hall Plastic Surgery does not place Allergan’s textured implants. All Allergan implants currently placed at this practice are smooth-shell silicone or saline, which carry a very low BIA-ALCL risk profile comparable to other smooth implant systems.
The INSPIRA® round silicone collection is available in five projection profiles: Soft Touch (low projection, widest base), Moderate (balanced), Full (the most commonly placed profile at Hall Plastic Surgery — noticeably forward projection with moderate-narrow base), Extra Full (high concentrated projection), and High (maximum projection per base width). Profile selection at Hall Plastic Surgery is based on chest wall base width measurement and desired volume and projection — not cup size targets.
ConfidencePlus® is Allergan’s implant warranty and patient protection program. It provides replacement implants at no charge for confirmed silicone gel rupture (lifetime coverage) and significantly reduced surgical fees for capsular contracture Grade III or IV within 10 years of the original surgery. The program has a long operational history and clear documented terms. Patients receive their ConfidencePlus® registration information at surgery — coverage is activated at the time of implantation.
Allergan’s primary advantages are full FDA PMA approval, the longest available post-market safety dataset, the broadest profile range, saline availability, and an established warranty program. Motiva’s primary advantages are the most natural progressive gel feel, the Ergonomix® gravity-responsive movement profile, TrueMonobloc® ripple reduction (most significant in thin-tissue patients), and Q Inside® NFC traceability. For patients with adequate tissue coverage who prioritize FDA approval and long-term data, Allergan is typically Dr. Hall’s recommendation. For thin-tissue patients where rippling and feel are the primary concerns, Motiva’s engineering advantages are more clinically significant.
Allergan silicone implants (FDA-approved 22+) are pre-filled with cohesive silicone gel, feel more like natural tissue, and are less prone to visible rippling — particularly in patients with thin tissue coverage. If the shell ruptures, silicone gel rupture is “silent” and requires MRI screening to detect. Allergan saline implants (FDA-approved 18+) are filled with sterile saline after insertion, allowing a slightly smaller incision. Saline rupture is immediately visible as the implant deflates. Saline implants feel firmer and ripple more visibly than silicone, particularly in thin-tissue patients.
Allergan saline breast implants are FDA-approved for augmentation in patients 18 and older. Allergan silicone gel implants are FDA-approved for augmentation in patients 22 and older. Patients between 18 and 21 who meet all other candidacy criteria and prefer implants over waiting are candidates for Allergan saline augmentation. Dr. Hall discusses the silicone versus saline trade-offs explicitly with younger patients so the decision is fully informed.
Allergan implants do not have a fixed replacement schedule. The FDA’s post-approval study data shows cumulative rupture rates of approximately 1–3% at 10 years for silicone implants — meaning the large majority of patients have intact implants at a decade post-surgery. Many patients keep their original Allergan implants for 15–20+ years without complication. The FDA recommends MRI screening for silicone implants at 3 years post-implantation and every 2 years thereafter to screen for silent rupture. Replacement is indicated if rupture is confirmed, capsular contracture requires surgical treatment, or aesthetic goals change.
Yes. Allergan INSPIRA® silicone or saline implants can be placed as the breast augmentation component of a Mommy Makeover. Implant system selection for combination surgery follows the same criteria as standalone augmentation. For post-pregnancy patients who have experienced significant volume loss and tissue changes, Dr. Hall’s profile selection may favor higher-projection Allergan options to restore upper pole fill — discussed and confirmed with physical sizers at consultation.
Yes. Patient financing is available through several partners, including 0% APR options for qualified applicants. Visit the financing page for current options and to apply online. Allergan implant and total procedure pricing is discussed at consultation.
Two Austin-area locations.
Hall Westlake
300 Beardsley Lane, Bldg C Ste 101
Austin, TX 78746
Mon–Thu: 9:00 AM – 5:00 PM
Fri: 9:00 AM – 3:00 PM
Accredited on-site surgical facility — all Allergan procedures performed here
Call (512) 327-5337Hall Cedar Park
301 Denali Pass Dr Suite 6
Cedar Park, TX 78613
Mon, Tue, Wed, Fri: 9:00 AM – 5:00 PM
Thu: By appointment
Consultations & medspa services — surgery at Westlake
Call (512) 327-5337Schedule your breast augmentation consultation.
Consultations are in-person and with Dr. Hall personally. He’ll examine your anatomy, measure your chest wall, walk you through the Allergan profile range with sizers, and give you a direct recommendation — including an honest comparison with Motiva if you want both options presented. Appointments at Westlake and Cedar Park.